Takehiko Okamura

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMedical physicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 14, 2026
Sequential Enzalutamide-Docetaxel Versus Abiraterone-Docetaxel Therapy in Castration-Resistant Prostate Cancer: A Subanalysis of the ENABLE Study.

|Aug 04, 2020
Primary diffuse large B-cell lymphoma of the ileal conduit created after radical cystectomy.

Takashi Nagai, Takehiko Okamura, Komei Katayama

|Oct 27, 2019
Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients with Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy.

Takashi Nagai, Taku Naiki, Keitaro Iida

|Jun 01, 2019
Extramedullary plasmacytoma of the ureter in an HIV-positive patient.

Takashi Nagai, Takehiko Okamura, Yosuke Taki

|Jun 22, 2017
A Study of Patients with Primary Mediastinal Germ Cell Tumors Treated Using Multimodal Therapy.

Yutaro Tanaka, Takehiko Okamura, Takashi Nagai

Pageof 1

Frequent Collaborators

1 joint publications

Yutaro Tanaka

1 joint publications

Yoshinobu Moritoki

1 joint publications

Manabu Kamiyama

1 joint publications

Kouji Izumi